TAI · —

Standard Chemical & Pharmaceutical Co., Ltd. (1720.TW) Stock

$56.80 -1.90% TAI: 1720.TW —

—

Valuation

MetricValue
Price$56.80
Market Cap$11.32B
P/E Ratio11.57
P/B Ratio1.66
P/S Ratio1.60
EPS (TTM)$4.98
52-Week High$60.55
52-Week Low$49.91
Dividend Yield3.45%

Financials & Margins

MetricValue
ROE15.39%
ROA7.59%
ROCE—
Gross Margin42.60%
Operating Margin21.78%
Net Margin14.51%
Debt/Equity0.09
Current Ratio2.18

Latest News

Life Insurance Stocks Q2 Recap: Benchmarking Globe Life (NYSE:GL) StockStory · Sep 14, 2026 Debt didn't top the list. Gambling did. A new Northwestern Mutual survey found that excessive gambling and risk-taking is the No. 1 financial red flag Americans look for in a relationship, cited by 49% of respondents. Hiding or lying about purchases (47%) and high credit card debt (41%) rounded out the top three, followed by impulse spending, expecting a partner to cover every bill, living paycheck to paycheck and a lack of savings. Researchers point to how normalized high-risk betting has become, from sports betting apps to prediction markets, especially among younger generations who are also reporting the most financial strain in their relationships. Which one of these would be a dealbreaker for you? Yahoo Finance · Sep 14, 2026 Bitzero Files Final Short Form Base Shelf Prospectus, Announces Effectiveness of U.S. Registration Statement and Files Prospectus Supplements TMX Newsfile · Sep 14, 2026 Bell AI Fabric Plans to Expand Saskatchewan Power Capacity by Up to 900 MW MT Newswires · Sep 14, 2026 Stocks pop when the Trump administration invests, but the gains often fade fast Yahoo Finance · Sep 14, 2026

Valuation & Return Ratios

MetricValue
PEG Ratio16.33
EV / EBITDA6.43
FCF Yield—
Quick Ratio1.48
Interest Coverage—
Return 1Y17.68%
Return 3Y20.19%
Return 5Y101.52%

Ownership

Insiders Held55.79%
Institutions Held1.07%
Institutions Float Held2.42%

About Standard Chemical & Pharmaceutical Co., Ltd.

—

Standard Chemical & Pharmaceutical Co., Ltd. is led by CEO Tzu-Ting Fan, employs 1,130 people, headquartered in Tainan City, TW, publicly traded since 2000.

Standard Chemical & Pharmaceutical Co., Ltd. (1720.TW) stock trades at $56.80 with a market capitalization of $11.32B. The stock is valued at a price-to-earnings (P/E) ratio of 11.57, price-to-book of 1.66, price-to-sales of 1.60. Over the past 52 weeks the stock has ranged between $49.91 and $60.55, and currently trades 6.2% below its 52-week high. It pays a dividend yielding 3.45%.

On profitability, Standard Chemical & Pharmaceutical Co., Ltd. generates a return on equity (ROE) of 15.39%, above the typical market range of roughly 12-15%, an operating margin of 21.78%, a net profit margin of 14.51%.

Official website: www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. (1720.TW) — frequently asked questions

What is Standard Chemical & Pharmaceutical Co., Ltd. (1720.TW) stock price today?

Standard Chemical & Pharmaceutical Co., Ltd. (1720.TW) is currently trading at $56.80, down 1.9% today.

What is 1720.TW P/E ratio?

Standard Chemical & Pharmaceutical Co., Ltd.'s P/E ratio is 11.57. This is below the typical market average of roughly 18-22x. A low P/E can reflect a lower valuation, slower expected growth, or both.

What is 1720.TW return on equity (ROE)?

Standard Chemical & Pharmaceutical Co., Ltd.'s return on equity (ROE) is 15.39%. ROE measures net income relative to shareholders' equity. This is above the typical market range of roughly 12-15%.

What is Standard Chemical & Pharmaceutical Co., Ltd.'s market cap?

Standard Chemical & Pharmaceutical Co., Ltd. has a market capitalization of $11.32B.

Does 1720.TW pay a dividend?

Yes. Standard Chemical & Pharmaceutical Co., Ltd. currently yields 3.45%. Yield moves with the share price, so it changes daily even when the payment does not.

How much debt does 1720.TW carry?

Standard Chemical & Pharmaceutical Co., Ltd. has a debt-to-equity ratio of 0.09. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is 1720.TW's profit margin?

Standard Chemical & Pharmaceutical Co., Ltd. reports a net profit margin of 14.51% — the share of revenue left after every cost, including tax and interest.

What sector is 1720.TW in?

Standard Chemical & Pharmaceutical Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is 1720.TW listed on?

Standard Chemical & Pharmaceutical Co., Ltd. trades on TAI under the ticker 1720.TW.

What is 1720.TW's 52-week range?

Over the last year Standard Chemical & Pharmaceutical Co., Ltd. has traded between $49.91 and $60.55.

Related — Stocks

USDE StablecoinX Inc. $1.00 -0.01% APMD Apnimed, Inc. $18.99 +2.48% GLAS Glass House Brands Inc. Subordinate Voting Shares $2.14 -6.14% GIXI Gix Internet Ltd. $4.23 +4.44%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens 1720.TW currently matches

On the figures above, Standard Chemical & Pharmaceutical Co., Ltd. passes the filters for 21 of our ready-made screens, among them Undervalued Stocks, Low PE Stocks, Cheap Stocks To Buy Now. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Undervalued StocksLow PE StocksCheap Stocks To Buy NowUndervalued Large Cap StocksUndervalued Dividend StocksDividend StocksLow Debt Dividend StocksLow Debt StocksLarge Cap StocksStocks With Insider BuyingStock Screener StarterFree Stock Screener PicksStocks With PE Under 20Stocks Under $100Large Cap Dividend StocksDividend Yield Over 3%Stocks With PE Under 25Stocks With PE Under 30Debt to Equity Below 1 StocksHigh Current Ratio StocksLow Debt Large Cap Stocks

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.